Redeye leaves a comment following Alzinova’s announcement of the appointment of Tord Labuda as the n...
Redeye initiates coverage of Cinclus Pharma, a Swedish biotech company offering a next-generation so...
Redeye provides some thoughts on and background to the SOLARIO study, which will be presented next w...
Redeye provides a brief comment on the expansion of the Digital Extremes development agreement, whic...
Redeye positively reviews the Thermo Fisher deal’s potential and the company’s US sales outlook.
Continued sales ramp-up, 32% sales growth q-o-q (ABGSCe +18%) Positive EBIT in FY'24/'25e, ests.
Redeye initiates coverage of Dala Energi, a group consisting of four business segments and five asso...
Redeye comments on EveryMatrix’s cash offer to acquire Fantasma Games at a price of SEK59 per share,...
Medisol, a European e-commerce specialist,... ...becomes Safe Life's 27th acquisition.
Mangold uppdaterar sin syn på greentech-bolaget ChargePanel efter det andra kvartalet 2024.
Redeye provides a brief comment on WntResearch’s initial phase 2 data.
Clean Motion AB (”Clean Motion” eller ”Bolaget”) utvecklar och erbjuder hållbara transportlösningar ...
VBG Groups andra kvartal visade på en viss nedgång men bolaget gynnas i nuläget av stark efterfrågan...
Redeye comments on the news about the company’s lower-than-expected number of patients who have achi...
CEO Jean Marie Mognetti participated in ABGSC Fireside Chat Focus on strategy, positioning and oppor...
